Development of plasma technology for the preparation and modification of energy storage materials.

Chem Commun (Camb)

Research Center of Nano Science and Technology, Department of Chemistry, College of Sciences, Shanghai University, Shanghai 200444, China.

Published: March 2024

The development of energy storage material technologies stands as a decisive measure in optimizing the structure of clean and low-carbon energy systems. The remarkable activity inherent in plasma technology imbues it with distinct advantages in surface modification, functionalization, synthesis, and interface engineering of materials. This review systematically expounds upon the principles, classifications, and application scenarios of plasma technology, while thoroughly discussing its unique merits in the realm of modifying electrode materials, solid-state electrolytes, and conductive carbon materials, which are widely used in lithium-ion batteries, sodium ion batteries, metal air batteries and other fields. Finally, considering the existing constraints associated with lithium-ion batteries, some application prospects of plasma technology in the energy storage field are suggested. This work is of great significance for the development of clean plasma technology in the field of energy storage.

Download full-text PDF

Source
http://dx.doi.org/10.1039/d3cc05341eDOI Listing

Publication Analysis

Top Keywords

plasma technology
20
energy storage
16
lithium-ion batteries
8
technology
5
energy
5
development plasma
4
technology preparation
4
preparation modification
4
modification energy
4
storage
4

Similar Publications

Hepatic encephalopathy (HE) is a syndrome that arises from acute or chronic liver failure. This study was devised to assess the impact of a combination of boswellic acid (BA) and low doses of gamma radiation (LDR) on thioacetamide (TAA)-induced HE in an animal model. The effect of daily BA treatment (175 mg/kg body weight, for four weeks) and/or fractionated low-dose γ-radiation (LDR; 0.

View Article and Find Full Text PDF

Specific plasma metabolite profile in intestinal Behçet's syndrome.

Orphanet J Rare Dis

January 2025

Department of Rheumatology and Immunology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, Fujian, China.

Background: Intestinal Behçet's syndrome (IBS) has high morbidity and mortality rates with serious complications. However, there are few specific biomarkers for IBS. The purposes of this study were to investigate the distinctive metabolic changes in plasma samples between IBS patients and healthy people, active IBS and inactive IBS patients, and to identify candidate metabolic biomarkers which would be useful for diagnosing and predicting IBS.

View Article and Find Full Text PDF

Trends in blood transfusion and causes of blood wastage: a retrospective analysis in a teaching hospital.

BMC Health Serv Res

January 2025

Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, 666 Buzih Road, Taichung, 40601, Taiwan.

Background: Blood is a vital medical resource that is sourced from primarily nonremunerated donations. As Taiwan faces an aging population, increasing medical demands pose new challenges to blood resource management. Trend analysis can improve blood supply chain management and allocate blood resources more efficiently and cost-effectively.

View Article and Find Full Text PDF

Background: Plasma proteins contribute to the identification, diagnosis, and prognosis of human illnesses, which may be conducive to understanding the molecular mechanism and diagnosis of Lung adenocarcinoma (LUAD).

Methods: We collected plasma samples from 28 healthy individuals (H) and 56 LUAD patients and analyzed them using LC-MS/MS-based proteomics to determine differential expression plasma proteins (DEPPs). Then, the DEPPs were subjected to a two-sample Mendelian randomization (MR) study based on an "Inverse variance weighted (IVW)" approach to investigate the causal relationships between DEPPs and LUAD.

View Article and Find Full Text PDF

Titin fragment is a sensitive biomarker in Duchenne muscular dystrophy model mice carrying full-length human dystrophin gene on human artificial chromosome.

Sci Rep

January 2025

Department of Chromosome Biomedical Engineering, School of Life Science, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683‑8503, Japan.

Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder caused by mutations of the dystrophin gene, which spans 2.4 Mb on the X chromosome. Creatine kinase (CK) activity in blood and titin fragment levels in urine have been identified as biomarkers in DMD to monitor disease progression and evaluate therapeutic intervention.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!